Aarey Drugs & Pharmaceuticals Hits Upper Circuit Limit Amid Strong Market Performance
Aarey Drugs & Pharmaceuticals Ltd has gained attention by reaching its upper circuit limit, with significant trading activity and a total volume of approximately 0.40756 lakh shares. The stock is currently above its key moving averages, indicating a positive trend, despite a decline in delivery volume.
Aarey Drugs & Pharmaceuticals Ltd, a microcap company in the trading industry, has made headlines today by hitting its upper circuit limit. The stock reached a high price of 55.5, reflecting a notable change of 1.09, which translates to a percentage increase of 2.06. The last traded price stood at 53.95, with a low of 53.0 during the trading session.In terms of trading activity, Aarey Drugs recorded a total traded volume of approximately 0.40756 lakh shares, resulting in a turnover of around Rs 0.2202 crore. The stock has outperformed its sector by 1.22%, indicating strong relative performance. Additionally, Aarey Drugs is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, showcasing a positive trend in its price movement.
Despite a decline in delivery volume, which fell by 31.61% compared to the 5-day average, the stock remains liquid enough for trading activities. Overall, Aarey Drugs & Pharmaceuticals Ltd has demonstrated robust performance today, reflecting its strong market position within the trading sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
